A 1-year randomized controlled study of everolimus versus mycophenolate mofetil with reduced-dose cyclosporine in maintenance heart transplant recipients

Background - The aim of this study was to demonstrate noninferiority of everolimus with reduced cyclosporine (CsA) vs mycophenolate mofetil (MMF) with reduced CsA in improving renal function. - Methods - In this 1-year randomized, open-label, noninferiority study in maintenance heart transplant reci...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bara, Christoph Leon (VerfasserIn) , Dengler, Thomas (VerfasserIn) , Hack, M. A. (VerfasserIn) , Ladenburger, S. (VerfasserIn) , Lehmkuhl, Hans Brendan (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 13 August 2013
In: Transplantation proceedings
Year: 2013, Jahrgang: 45, Heft: 6, Pages: 2387-2392
ISSN:1873-2623
DOI:10.1016/j.transproceed.2013.03.032
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.transproceed.2013.03.032
Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0041134513005010
Volltext
Verfasserangaben:C. Bara, T. Dengler, M.A. Hack, S. Ladenburger and H.B. Lehmkuhl

MARC

LEADER 00000caa a2200000 c 4500
001 1737638320
003 DE-627
005 20240407193420.0
007 cr uuu---uuuuu
008 201103s2013 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.transproceed.2013.03.032  |2 doi 
035 |a (DE-627)1737638320 
035 |a (DE-599)KXP1737638320 
035 |a (OCoLC)1341375387 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Bara, Christoph Leon  |d 1955-  |e VerfasserIn  |0 (DE-588)139440925  |0 (DE-627)610421840  |0 (DE-576)311773834  |4 aut 
245 1 2 |a A 1-year randomized controlled study of everolimus versus mycophenolate mofetil with reduced-dose cyclosporine in maintenance heart transplant recipients  |c C. Bara, T. Dengler, M.A. Hack, S. Ladenburger and H.B. Lehmkuhl 
246 3 3 |a A one-year randomized controlled study of everolimus versus mycophenolate mofetil with reduced-dose cyclosporine in maintenance heart transplant recipients 
264 1 |c 13 August 2013 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 03.11.2020 
520 |a Background - The aim of this study was to demonstrate noninferiority of everolimus with reduced cyclosporine (CsA) vs mycophenolate mofetil (MMF) with reduced CsA in improving renal function. - Methods - In this 1-year randomized, open-label, noninferiority study in maintenance heart transplant recipients with impaired renal function 70 patients received everolimus (n = 36) or MMF (n = 34) in combination with reduced CsA. The planned sample size was not reached as the study was prematurely discontinued due to slow recruitment. - Results - Noninferiority of the everolimus regimen could not be shown: In the total population MMF seemed to be favorable on renal function assessed by serum creatinine and filtration rates, but not in the subset of patients who reached the intended reduced CsA level. Incidence rates of rejection episodes were significantly higher under MMF at month 6 (P = .0332). - Conclusions - Overall, the results of this trial using reduced CsA in combination with either everolimus or MMF show that there is evidence to reduce the CsA level when everolimus is given concomitantly and that the benefit of MMF with reduced CsA levels is limited due to insufficient immunosuppression. 
700 1 |a Dengler, Thomas  |e VerfasserIn  |0 (DE-588)1077763050  |0 (DE-627)837469198  |0 (DE-576)184645417  |4 aut 
700 1 |a Hack, M. A.  |e VerfasserIn  |4 aut 
700 1 |a Ladenburger, S.  |e VerfasserIn  |4 aut 
700 1 |a Lehmkuhl, Hans Brendan  |d 1965-  |e VerfasserIn  |0 (DE-588)1013399870  |0 (DE-627)664167128  |0 (DE-576)347052118  |4 aut 
773 0 8 |i Enthalten in  |t Transplantation proceedings  |d Amsterdam [u.a.] : Elsevier Science, 1997  |g 45(2013), 6, Seite 2387-2392  |h Online-Ressource  |w (DE-627)306710870  |w (DE-600)1500785-6  |w (DE-576)082436088  |x 1873-2623  |7 nnas  |a A 1-year randomized controlled study of everolimus versus mycophenolate mofetil with reduced-dose cyclosporine in maintenance heart transplant recipients 
773 1 8 |g volume:45  |g year:2013  |g number:6  |g pages:2387-2392  |g extent:6  |a A 1-year randomized controlled study of everolimus versus mycophenolate mofetil with reduced-dose cyclosporine in maintenance heart transplant recipients 
856 4 0 |u https://doi.org/10.1016/j.transproceed.2013.03.032  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0041134513005010  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20201103 
993 |a Article 
994 |a 2013 
998 |g 1077763050  |a Dengler, Thomas  |m 1077763050:Dengler, Thomas  |d 50000  |e 50000PD1077763050  |k 0/50000/  |p 2 
999 |a KXP-PPN1737638320  |e 3791598260 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title_sort":"1-year randomized controlled study of everolimus versus mycophenolate mofetil with reduced-dose cyclosporine in maintenance heart transplant recipients","title":"A 1-year randomized controlled study of everolimus versus mycophenolate mofetil with reduced-dose cyclosporine in maintenance heart transplant recipients"}],"person":[{"family":"Bara","given":"Christoph Leon","display":"Bara, Christoph Leon","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","display":"Dengler, Thomas","roleDisplay":"VerfasserIn","given":"Thomas","family":"Dengler"},{"given":"M. A.","family":"Hack","role":"aut","roleDisplay":"VerfasserIn","display":"Hack, M. A."},{"given":"S.","family":"Ladenburger","role":"aut","display":"Ladenburger, S.","roleDisplay":"VerfasserIn"},{"display":"Lehmkuhl, Hans Brendan","roleDisplay":"VerfasserIn","role":"aut","family":"Lehmkuhl","given":"Hans Brendan"}],"titleAlt":[{"title":"A one-year randomized controlled study of everolimus versus mycophenolate mofetil with reduced-dose cyclosporine in maintenance heart transplant recipients"}],"recId":"1737638320","language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 03.11.2020"],"id":{"eki":["1737638320"],"doi":["10.1016/j.transproceed.2013.03.032"]},"origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"13 August 2013"}],"name":{"displayForm":["C. Bara, T. Dengler, M.A. Hack, S. Ladenburger and H.B. Lehmkuhl"]},"relHost":[{"origin":[{"publisherPlace":"Amsterdam [u.a.]","publisher":"Elsevier Science","dateIssuedKey":"1997","dateIssuedDisp":"1997-"}],"id":{"zdb":["1500785-6"],"eki":["306710870"],"issn":["1873-2623"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Transplantation proceedings","title":"Transplantation proceedings"}],"pubHistory":["Nachgewiesen 29.1997 -"],"part":{"text":"45(2013), 6, Seite 2387-2392","volume":"45","extent":"6","year":"2013","pages":"2387-2392","issue":"6"},"disp":"A 1-year randomized controlled study of everolimus versus mycophenolate mofetil with reduced-dose cyclosporine in maintenance heart transplant recipientsTransplantation proceedings","note":["Gesehen am 04.08.05","Ungezählte Beil.: Supplement"],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"recId":"306710870"}],"physDesc":[{"extent":"6 S."}]} 
SRT |a BARACHRIST1YEARRANDO1320